We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Directorate for the Quality of Medicines and a number of foreign pharmaceutical authorities have agreed to improve information-sharing efforts and to strengthen collaboration. Read More
After the FDA clamped down on its facilities most of the year, Lupin has received clearance from the agency to produce drugs again at its site in Goa, India. Read More
Five generics drugmakers are facing a class action lawsuit for allegedly colluding to inflate the price of a historically affordable generic anticonvulsant by more than 500 percent. Read More
The European Medicines Agency adopted a final guideline setting out the information required for the evaluation of active chemical substances used in drug products. Read More
With just three work weeks left in its lame duck session, many are expecting the Senate to vote on its 21st Century Cures legislation package. Read More